A high-performance liquid chromatography method using ultraviolet detection for the quantitation of flavopiridol from human plasma

Biomedical Chromatography

Volumn 16, Issue 6, 2002, Pages 379-382

  Zhai, Suoping ^a   Sausville, Edward ^a   Figg, William D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA (HUMAN); PRECIPITATION (CHEMICAL);

CELL/B.E; CONCENTRATION RANGES; CYCLIN-DEPENDENT KINASE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN PLASMAS; KEY REGULATORS; KINASE A; ULTRA VIOLET DETECTION; ULTRAVIOLET DETECTION; UMBELLIFERONE;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ACETONITRILE; AMMONIUM ACETATE; CYCLIN DEPENDENT KINASE; FLAVOPIRIDOL; METHANOL; UMBELLIFERONE;

ARTICLE; BLOOD SAMPLING; CELL CYCLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROCHEMICAL ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; METHODOLOGY; PRECIPITATION; QUANTITATIVE ANALYSIS; RADIATION DETECTION; SEPARATION TECHNIQUE; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 0036738859     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.166     Document Type: Article

References (6)

1. Sausville EA, Zaharevitz D, Gussio R, Meijer L, Louarn-Leost M, Kunick C, Schultz R, Lahusen T, Headlee D, Stinson S, Arbuck SG and Senderowicz A. Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target. Pharmacology Therapy 1999; 82(2-3): 285-292.
2. Senderowicz A, Headlee D, Stinson SF, Lush RM, Kalil N, Villalba L, Hill K, Figg WD, Tompkins A, Arbuck SG, Murgo A and Sausville EA. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasmas. Journal of Clinical Oncology 1998; 16(9): 2986-2999.
3. Senderowicz AM and Sausville EA. Preclinical and clinical development of cyclin-dependent kinase modulators. Journal of National Cancer Institute 2000; 92(5): 376-387.
4. Stadler WM, Vogelzang NJ, Amato R, Sosman J, Taber D, Liebowitz A. and Vokes E. Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a university of Chicago phase II consortium study. Journal of Clinical Oncology 2000; 18(2): 371-375.
5. Stinson SF, Hill K, Siford TJ, Phillips LR and Daw TW. Cancer Chemotherapy Pharmacology 1998; 42: 261-265.
6. Zhai S, Figg, WD, Headlee D, Messmann RA, Arbuck SG, Murgo A, Melillo G and Sausville EA, Senderowicz AM. Pharmacokinetics of flavopiridol 1 hour infusion in patients with refractory neoplasms. 11th NCI-EORTC-AACR Symposium, 2000; 314.